Cargando…
APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling
BACKGROUND: 5-Fluorouracil(5FU) and oral analogues, such as capecitabine, remain one of the most useful agents for the treatment of colorectal adenocarcinoma. Low toxicity and convenience of administration facilitate use, however clinical resistance is a major limitation. Investigation has failed to...
Autores principales: | Petty, Russell D, Samuel, Leslie M, Murray, Graeme I, MacDonald, Graham, O'Kelly, Terrence, Loudon, Malcolm, Binnie, Norman, Aly, Emad, McKinlay, Aileen, Wang, Weiguang, Gilbert, Fiona, Semple, Scot, Collie-Duguid, Elaina SR |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801520/ https://www.ncbi.nlm.nih.gov/pubmed/20003335 http://dx.doi.org/10.1186/1471-2407-9-434 |
Ejemplares similares
-
Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer
por: Matula, Kasia, et al.
Publicado: (2015) -
The Art of People Management in Libraries
por: McKinlay, James
Publicado: (2010) -
The Basis of Standard Tables of Body Weight
por: McKinlay, P. L.
Publicado: (1935) -
A Note on the Mortality from Pernicious Anæmia in Scotland, with Special Reference to the Influence of Liver Treatment
por: McKinlay, Peter L.
Publicado: (1930) -
Certain Types of Alimentary Neurosis
por: McKinlay, Peter C.
Publicado: (1937)